COMPASS PATHWAYS PLC Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
COMPASS PATHWAYS PLC (CMPS) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 17.89 thousand shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2023-02-28
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2021-12-31 was 45.27K shares.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2022 was 17.89K shares, a 69.09% decline from fiscal 2021.
- COMPASS PATHWAYS PLC share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2021 was 57.88K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month |
|---|---|---|---|
| 2022-12-31 | 17.89K shares 10-K · filed 2023-02-28 | ||
| 2021-12-31 | 45.27K shares derived: 10-K 12 month − 6-K 9 month · filed 2023-02-28 | 57.88K shares 10-K · filed 2023-02-28 | |
| 2021-09-30 | 12.61K shares 6-K · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |